Abstract
Objectives: The NIH-Chronic Prostatitis Symptom Index (NIH-CPSI) was developed to assess symptoms and quality of life in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). We assessed the responsiveness of the NIH-CPSI to change over time and defined thresholds for changes perceptible to patients. Methods: We studied 174 men with CP/CPPS who participated in a placebo-controlled randomized clinical trial. Changes from baseline to six weeks in the NIH-CPSI total score and pain, urinary, and quality of life subscores were compared to a global response assessment (GRA). Effect sizes and Guyatt statistics were calculated to evaluate responsiveness; 95% confidence intervals were produced using bootstrapping. Results: All scores decreased over time with the largest decrease in subjects who reported on the GRA that they were markedly improved. The NIH-CPSI total, pain, and quality of life scores were highly responsive in the improved groups; the urinary score showed minimal responsiveness. There was no evidence of responsiveness among those subjects who worsened on the trial. ROC curves identified a 6-point decline in the NIH-CPSI total score as the optimal threshold to predict treatment response. Conclusions: The NIH-CPSI total score and pain and quality of life subscores are responsive to change over␣time.
Similar content being viewed by others
References
MS Litwin M McNaughton-Collins FJJ Fowler et al. (1999) ArticleTitleThe National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure J Urol 162 369–375 Occurrence Handle10.1016/S0022-5347(05)68562-X Occurrence Handle1:STN:280:DyaK1Mzjs1yhsA%3D%3D Occurrence Handle10411041
M McNaughton-Collins MP O’Leary EA Calhoun et al. (2001) ArticleTitleThe Spanish National Institutes of Health-Chronic Prostatitis Symptom Index: translation and linguistic validation J Urol 166 1800–1803
KJ Propert RB Alexander JC Nickel et al. (2002) ArticleTitleDesign of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome Urology 59 870–876 Occurrence Handle10.1016/S0090-4295(02)01601-1 Occurrence Handle12031372
RB Alexander KJ Propert AJ Schaeffer et al. (2004) ArticleTitleCiprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial Ann Intern Med 141 581–589 Occurrence Handle1:CAS:528:DC%2BD2cXpslCqurg%3D Occurrence Handle15492337
J Cohen (1988) Statistical Power Analysis for the Behavioral Sciences Lawrence Erlbaum Associates Hillsdale, NJ 381
G Guyatt S Walter G Norman (1987) ArticleTitleMeasuring change over time: assessing the usefulness of evaluative instruments J Chron Dis 40 171–178 Occurrence Handle1:STN:280:BiiC3sfhtFE%3D Occurrence Handle3818871
B Efron RJ Tibshirani (1993) An Introduction to the Bootstrap Chapman and Hall San Francisco
RA Deyo P Diehr DL Patrick (1991) ArticleTitleReproducibility and responsiveness of health status measures. Statistics and strategies for evaluation Controlled Clinical Trials 12 142S–158S Occurrence Handle1:STN:280:By2C3snotFE%3D Occurrence Handle1663851
M McNaughton-Collins MA Pontari MP O’Leary et al. (2001) ArticleTitleQuality of life is impaired in men with chronic prostatitis J Gen Intern Med 16 656–662 Occurrence Handle1:STN:280:DC%2BD3MnjsFegug%3D%3D Occurrence Handle11679032
JA Turner MA Ciol M Korff ParticleVon R Berger (2003) ArticleTitleValidity and responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index J Urol 169 580–583 Occurrence Handle10.1016/S0022-5347(05)63957-2 Occurrence Handle12544311
GH Guyatt LB Berman M Townsend DW Taylor (1985) ArticleTitleShould study subjects see their previous responses? J Chron Dis 38 1003 Occurrence Handle1:STN:280:BimD2MbptFc%3D Occurrence Handle4066888
MJ Barry WO Williford Y Chang et al. (1995) ArticleTitleBenign prostatic hyperplasia specific health status measures in clinical research: How much change in the American Urological Association Symptom Index and the Benign Prostatic Hyperplasia Impact Index is perceptible to patients? J Urol 154 1770–1774 Occurrence Handle10.1016/S0022-5347(01)66780-6 Occurrence Handle1:STN:280:BymD3cfktFQ%3D Occurrence Handle7563343
RO Roberts DJ Jacobson CJ Girman T Rhodes MM Lieber SJ Jacobsen (2002) ArticleTitlePrevalence of prostatitis-like symptoms in a community based cohort of older men J Urol 168 2467 Occurrence Handle10.1016/S0022-5347(05)64170-5 Occurrence Handle12441942
JC Nickel J Downey D Hunter J Clark (2001) ArticleTitlePrevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index J Urol 165 842 Occurrence Handle1:STN:280:DC%2BD3M3jtlaqsA%3D%3D Occurrence Handle11176483
DA Shoskes SI Zeitlin A Shahed J Rajfer (1999) ArticleTitleQuercetin in men with category III chronic prostatitis: a preliminary prospective, double-blind, placebo-controlled trial Urology 54 960 Occurrence Handle10.1016/S0090-4295(99)00358-1 Occurrence Handle1:STN:280:DC%2BD3c%2FmvVWruw%3D%3D Occurrence Handle10604689
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Propert, K.J., Litwin, M.S., Wang, Y. et al. Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI). Qual Life Res 15, 299–305 (2006). https://doi.org/10.1007/s11136-005-1317-1
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11136-005-1317-1